Caisse Des Depots ET Consignations Takes Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Caisse Des Depots ET Consignations purchased a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 4,297 shares of the company's stock, valued at approximately $336,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Cherry Creek Investment Advisors Inc. grew its stake in shares of GE HealthCare Technologies by 0.3% during the 4th quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company's stock valued at $2,920,000 after purchasing an additional 114 shares during the period. Independence Bank of Kentucky grew its position in GE HealthCare Technologies by 6.0% during the fourth quarter. Independence Bank of Kentucky now owns 2,018 shares of the company's stock valued at $158,000 after buying an additional 114 shares during the period. Haverford Trust Co raised its position in GE HealthCare Technologies by 2.4% in the fourth quarter. Haverford Trust Co now owns 4,896 shares of the company's stock worth $383,000 after acquiring an additional 115 shares during the period. Tandem Capital Management Corp ADV boosted its stake in shares of GE HealthCare Technologies by 0.4% during the 4th quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company's stock worth $2,205,000 after acquiring an additional 118 shares during the last quarter. Finally, Arcus Capital Partners LLC grew its position in shares of GE HealthCare Technologies by 3.0% during the 4th quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company's stock valued at $322,000 after acquiring an additional 119 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

GE HealthCare Technologies Price Performance

GEHC stock traded up $0.74 during trading on Monday, hitting $80.75. 1,930,291 shares of the company's stock traded hands, compared to its average volume of 3,091,737. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80. The stock has a market capitalization of $36.93 billion, a price-to-earnings ratio of 18.66, a P/E/G ratio of 3.19 and a beta of 1.13. The business has a fifty day simple moving average of $86.70 and a 200 day simple moving average of $85.86. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. As a group, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.17%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies's payout ratio is 3.23%.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. Citigroup boosted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and raised their target price for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.